The Political Economy of AIDS Treatment: Intellectual Property and the Transformation of Generic Supply
- 14 August 2007
- journal article
- Published by Oxford University Press (OUP) in International Studies Quarterly
- Vol. 51 (3) , 559-581
- https://doi.org/10.1111/j.1468-2478.2007.00464.x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- A Rewarding Engagement? The Treatment Action Campaign and the Politics of HIV/AIDSPolitics & Society, 2005
- The WTO Medicines Decision: World Pharmaceutical Trade and the Protection of Public HealthAmerican Journal of International Law, 2005
- AIDS Policy and Pharmaceutical Patents: Brazil's Strategy to Safeguard Public HealthThe World Economy, 2005
- How Do Patents And Economic Policies Affect Access To Essential Medicines In Developing Countries?Health Affairs, 2004
- Access to antiretroviral drugs in BrazilThe Lancet, 2002
- This Week in JAMAJAMA, 2002
- "We all have AIDS": case for reducing the cost of HIV drugs to zero Commentary: The reality of treating HIV and AIDS in poor countries Commentary: Most South Africans cannot afford anti-HIV drugsBMJ, 2002
- Do Patents for Antiretroviral Drugs Constrain Access to AIDS Treatment in Africa?JAMA, 2001
- Patent Protection, Transnational Corporations, and Market Structure: A Simulation Study of the Indian Pharmaceutical IndustryJournal of Industry, Competition and Trade, 2001
- GLOBAL PROPERTY RIGHTS IN INFORMATION: The story of TRIPS at the GATTPrometheus, 1995